chrX-9684109-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_005647.4(TBL1X):c.278C>T(p.Thr93Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000827 in 1,209,681 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000082 ( 0 hom. 3 hem. )
Consequence
TBL1X
NM_005647.4 missense
NM_005647.4 missense
Scores
2
4
11
Clinical Significance
Conservation
PhyloP100: 7.37
Genes affected
TBL1X (HGNC:11585): (transducin beta like 1 X-linked) The protein encoded by this gene has sequence similarity with members of the WD40 repeat-containing protein family. The WD40 group is a large family of proteins, which appear to have a regulatory function. It is believed that the WD40 repeats mediate protein-protein interactions and members of the family are involved in signal transduction, RNA processing, gene regulation, vesicular trafficking, cytoskeletal assembly and may play a role in the control of cytotypic differentiation. This encoded protein is found as a subunit in corepressor SMRT (silencing mediator for retinoid and thyroid receptors) complex along with histone deacetylase 3 protein. This gene is located adjacent to the ocular albinism gene and it is thought to be involved in the pathogenesis of the ocular albinism with late-onset sensorineural deafness phenotype. Four transcript variants encoding two different isoforms have been found for this gene. This gene is highly similar to the Y chromosome TBL1Y gene. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.322684).
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBL1X | NM_005647.4 | c.278C>T | p.Thr93Met | missense_variant | 6/18 | ENST00000645353.2 | |
TBL1X | NM_001139466.1 | c.278C>T | p.Thr93Met | missense_variant | 6/18 | ||
TBL1X | NM_001139467.1 | c.125C>T | p.Thr42Met | missense_variant | 5/17 | ||
TBL1X | NM_001139468.1 | c.125C>T | p.Thr42Met | missense_variant | 6/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBL1X | ENST00000645353.2 | c.278C>T | p.Thr93Met | missense_variant | 6/18 | NM_005647.4 |
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111468Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33676
GnomAD3 genomes
AF:
AC:
1
AN:
111468
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33676
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000218 AC: 4AN: 183502Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67932
GnomAD3 exomes
AF:
AC:
4
AN:
183502
Hom.:
AF XY:
AC XY:
3
AN XY:
67932
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1098213Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363569
GnomAD4 exome
AF:
AC:
9
AN:
1098213
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
363569
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111468Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33676
GnomAD4 genome
AF:
AC:
1
AN:
111468
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33676
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.278C>T (p.T93M) alteration is located in exon 6 (coding exon 3) of the TBL1X gene. This alteration results from a C to T substitution at nucleotide position 278, causing the threonine (T) at amino acid position 93 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;T;T;.;T;T;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;.;.;D;.;.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;.;L;L;.;L;L;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;D;N;.;N;.;.;.;.
REVEL
Benign
Sift
Uncertain
D;D;D;T;D;.;D;.;.;.;.
Sift4G
Uncertain
T;D;T;D;D;.;T;.;.;.;.
Polyphen
0.99
.;D;.;.;D;D;.;D;D;.;.
Vest4
MutPred
0.32
.;Loss of glycosylation at T93 (P = 0.0264);.;.;Loss of glycosylation at T93 (P = 0.0264);Loss of glycosylation at T93 (P = 0.0264);.;Loss of glycosylation at T93 (P = 0.0264);Loss of glycosylation at T93 (P = 0.0264);.;.;
MVP
MPC
1.5
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at